Literature DB >> 18093262

Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy.

Christopher Seungkyu Lee, Hyoung Jun Koh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18093262     DOI: 10.1111/j.1600-0420.2007.01111.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  6 in total

1.  Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

Authors:  Ahmad M Mansour; Maha Shahin; Peter K Kofoed; Maurizio B Parodi; Michel Shami; Stephen G Schwartz
Journal:  Clin Ophthalmol       Date:  2012-03-06

2.  An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agent.

Authors:  Er-Ning Su; Stephen J Cringle; Ian L McAllister; Dao-Yi Yu
Journal:  BMC Ophthalmol       Date:  2012-05-29       Impact factor: 2.209

3.  Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy.

Authors:  Aditya Kelkar; Poonam Gandhi; Winfried Amoaku; Jai Kelkar; Shreekant Kelkar; Priyanka Raut; Rachana Shah
Journal:  Case Rep Ophthalmol       Date:  2014-07-11

4.  Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye.

Authors:  Mohammadreza Peyman; Alireza Peyman; Van C Lansingh; Amirhossein Orandi; Visvaraja Subrayan
Journal:  J Curr Ophthalmol       Date:  2018-10-30

5.  The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions.

Authors:  Emine Ciloglu; Ayse Yıldırım Celikdemir
Journal:  Ther Clin Risk Manag       Date:  2019-07-04       Impact factor: 2.423

6.  Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients.

Authors:  Vincenzo Isola; Alfredo Pece; Claudio Massironi; Simone Reposi; Fabio Dimastrogiovanni
Journal:  Clin Ophthalmol       Date:  2013-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.